Company Profile
Company Introduction
　　Walvax Biotechnology Co., Ltd. (hereinafter referred to as Walvax) was founded in 2001, which is a modern biological pharmaceutical enterprise engaged in R & D, production and sales of bio-medicine products.
Products
  • Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed
  • 23-valent Pneumococcal Polysaccharide Vaccine
  • Group ACYW135 Meningococcal Polysaccharide Vaccine
  • Group A and C Meningococcal Polysaccharide Vaccine
  • Group A, C Meningococcal Polysaccharide Conjugate Vaccine, Freeze-dried
  • Haemophilus Influenzae Type b Conjugate Vaccine (Prefilled syringe)
  • Haemophilus Influenzae Type b Conjugate Vaccine
吉林心悦麻将老版本 极速快3走势图官网 快乐十分规则奖金 李逵劈鱼捕鱼机漏洞规律技巧破解 2元微信麻将群 吉林时时彩网站制作 河内五分彩倍投技巧 重庆快乐10分开奖号码 山西11选5预测论坛 七星彩走势图一体带连线 14场足彩比分直播 波场币发行价 云南麻将烂牌怎么糊 美网网球比分直播直播 mg电子游戏线 河内五分彩倍投技巧 北京时时彩玩法